About BB - NCIPD Ltd.

BB-NCIPD Ltd. is a commercial company, 100% state-owned, with over 130 years of history.

The management is introducing European standards in personnel training, staff motivation and incentives, improving constantly the educational and qualification level of the employees.

The production nomenclature covers more than 600 medicines, divided in two main groups: human medicines and in-vitro diagnostic medicine products. As result of the research and development activity of the company specialists, there have been implemented new technologies meeting the highest requirements of the international standards.

Eminent specialists, having higher education and highqualified specialists with secondary special education, who are 60% of the company personnel, work in the manufacturing, control and quality assurance.

Read more ...

News and events

Stablepharma and Partner BB-NCIPD Ltd (Bul Bio) sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine.

Published at: 2023-05-25

Stablepharma and Partner BB-NCIPD Ltd (Bul Bio) sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine. read more ...

Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement to produce the world’s first fridge-free Tetanus diphtheria vaccine

Published at: 2022-09-29

Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement read more ...